请使用支持JavaScript的浏览器! Enzolifesciences/RANKL monoclonal antibody (12A380)/ALX-804-244-C100/100µg-蚂蚁淘商城
新闻动态

Enzolifesciences/RANKL monoclonal antibody (12A380)/ALX-804-244-C100/100µg

  
  2025-05-11
  

Product Specification:

Alternative Name:ODF, TRANCE, OPGL, TNFSF 11, CD254
Clone:12A380
Host:Mouse
Isotype:IgG1
Immunogen:Recombinant mouse RANKL (aa 1-317).
UniProt ID:O35235
Species reactivity:Human, Mouse
Applications:Flow Cytometry, IHC (FS), WB
Recommended Dilutions/Conditions:Western Blot (4-6µg/ml)Suggested dilutions/conditions may not be available for all applications.Optimal conditions must be determined individually for each application.
Application Notes:Detects a band of ~40kDa by Western blot.
Positive Control:Activated EL4 cells (mouse) or Saos-2 (human) cells can be used as positive control.
Purity Detail:Protein G-affinity purified.
Formulation:Liquid. In PBS containing 0.05% BSA and 0.05% sodium azide.
Use/Stability:Stable for at least 6 months when stored at +4°C.
Shipping:Shipped on Blue Ice
Short Term Storage:+4°C
Long Term Storage:-20°C
Scientific Background:RANKL (TRANCE, OPGL, ODF) is a member of the TNF family. RANKL (receptor activator of NF-κB ligand) or TRANCE (TNF-related activation-induced cytokine receptor) has been implicated in interactions between T cells and dendritic cells. RANKL binds to RANK on dendritic cells, upregulates the expression of anti-apoptotic protein BcL-XL suggesting a role in dendritic cell survival. RANKL is also important in T- and B-cell maturation. As OPGL (osteoprotegerin ligand) or ODF (osteoclast differentiation factor), the same protein can both activate mature osteoclasts and mediate osteoclastogenesis. RANKL deficient mice show severe osteoporesis and complete abscence of osteoclasts as a result of lack of osteogenesis.

本文链接: https://www.ebiomall.cn/b89-enzo/info-1529205924.html

免责声明 本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容。
版权声明 未经蚂蚁淘授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘”。违反上述声明者,本网将追究其相关法律责任。
没有了